Results 31 to 40 of about 67,248 (260)

Glycogenic hepatopathy – An underrecognised cause of transaminitis in primary care settings: A case report [PDF]

open access: yesMalaysian Family Physician
Glycogenic hepatopathy (GH) is a rare but reversible hepatic condition associated with poorly controlled type 1 diabetes mellitus (T1DM). It results from excessive glycogen accumulation in hepatocytes, leading to hepatomegaly and elevated liver enzyme ...
Nordiyana Zainul Abidin   +3 more
doaj   +1 more source

Embryonal Hepatoblastoma with Co-existent Glycogen Storage Disease in a Seven-month-old Child [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2016
Hepatoblastoma is an uncommon malignant liver tumour diagnosed usually during the first three years of life. It presents as abdominal mass with elevated alpha fetoprotein levels. The definite diagnosis requires histopathological confirmation.
Nadia Shirazi   +3 more
doaj   +1 more source

Glycogen storage disease type 1a in the Ohio Amish

open access: yesJIMD Reports, 2022
Glycogen storage disease type 1a (GSD1a) is an inborn error of glucose metabolism characterized by fasting hypoglycemia, hepatomegaly, and growth failure. Late complications include nephropathy and hepatic adenomas.
Ethan M. Scott   +6 more
doaj   +1 more source

Clinical outcome of a patient with lysosomal acid lipase deficiency and first results after initiation of treatment with Sebelipase alfa: A case report [PDF]

open access: yes, 2019
We report on a case of very rare autosomal recessive cholesteryl ester storage disease due to lysosomal acid lipase deficiency (LALD). LALD is caused by mutations in the lysosomal acid lipase A (LIPA) gene resulting in cholesteryl ester accumulation in
Bobbert, Thomas   +8 more
core   +1 more source

Successful fenofibrate therapy for severe and persistent hypertriglyceridemia in a boy with cirrhosis and glycerol‐3‐phosphate dehydrogenase 1 deficiency

open access: yesJIMD Reports, 2020
Glycerol‐3‐phosphate dehydrogenase 1 deficiency is a rare autosomal recessive disorder caused by mutations in the GPD1 gene (GPD1; OMIM*138420). Very few cases are reported in literature.
Lorenza Matarazzo   +8 more
doaj   +1 more source

Evolving Features of RASopathies Among Pregnancies With Abnormal Fetal Fluid Collections. [PDF]

open access: yesPrenat Diagn
ABSTRACT Objective We aimed to characterize the fetal features across gestation and describe genotype‐phenotype correlations for pregnancies with fetal RASopathies that were more severely affected as they presented with at least one abnormal fluid collection.
Gulrajani NB   +17 more
europepmc   +2 more sources

Clinical manifestations of human brucellosis : a systematic review and meta-analysis [PDF]

open access: yes, 2012
BACKGROUND: The objectives of this systematic review, commissioned by WHO, were to assess the frequency and severity of clinical manifestations of human brucellosis, in view of specifying a disability weight for a DALY calculation.
Crump, L.   +5 more
core   +3 more sources

Radiografia quantitativa hepática de cães tranquilizados com acepromazina Hepatic quantitative radiography in dogs with acepromazine

open access: yesCiência Rural, 2011
O maleato de acepromazina é um dos tranquilizantes mais utilizados em medicina veterinária, podendo causar esplenomegalia, mas não é conhecida a possibilidade de ocorrência de hepatomegalia.
Bernardo Fernandes Lopes   +5 more
doaj   +1 more source

Prevalence of Gaucher’s Disease in a Hematology Outpatient Clinic

open access: yesJournal of Contemporary Medicine, 2020
Objective: Gaucher’s disease (GD) is a disease caused by glucocerebrosidase enzyme deficiency and characterized by glucoceramide accumulation in the reticuloendothelial system.
Didar Yanardağ Açık, Bilal Aygun
doaj   +1 more source

Developmental and Epileptic Encephalopathy due to Biallelic Pathogenic Variants in PIGM

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective PIGM encodes a critical enzyme in the glycosylphosphatidylinositol (GPI)‐anchor biosynthesis pathway. While promoter‐region mutations in PIGM have been associated with a relatively mild phenotype characterized by portal vein thrombosis and absence seizures, recent evidence suggests that coding‐region mutations result in a more severe
Júlia Sala‐Coromina   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy